Automated Exploration of Bioinformatics Spaces Simon Colton Computational Bioinformatics Laboratory.
Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation
description
Transcript of Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation
![Page 1: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/1.jpg)
Advanced BioinformaticsLecture 9: Drug resistant & cancerous mutation
http://idrb.cqu.edu.cn/Innovative Drug Research Centre in CQU
创新药物研究与生物信息学实验室
![Page 2: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/2.jpg)
1. Differential drug efficacy
2. Pharmacogenetics
3. Pharmacogenetic response
4. Drug resistance mutation
5. Prediction of drug resistance
Table of Content
2
![Page 3: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/3.jpg)
Same symptomsSame disease
Same drugSame doseDifferent Effects
Different patients
At a recommended prescribed dosage—
(1) a drug is efficacious in most;
(2) not efficacious in others;
(3) harmful in a few.
Lack of efficacy
Unexpected side-effects
Differential drug efficacy
3
![Page 4: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/4.jpg)
Patient population with same disease phenotype
Patients with normal response to drug therapy
Patients with non-response to drug therapy
Patients with drug toxicity
Genotyping
People react differently to drugs“One size does not fit all …”
4
Toxic responders
Non-responders
Responders
![Page 5: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/5.jpg)
EthnicityAgePregnancyGenetic factorsDiseaseDrug interactions……
Same symptomsSame disease
Same drugSame doseDifferent Effects
Different patients
Why does drug response vary?
5
Possible Reasons: Individual variationBy chance…
Genetic Differences
AA
GGSNP
![Page 6: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/6.jpg)
Primarily 2 types of genetic mutation events create all forms of variations:
Single base mutation which substitutes 1 nucleotide− Single nucleotide polymorphisms (SNPs)
Insertion or deletion of 1 or more nucleotide(s)− Tandem Repeat Polymorphisms
− Insertion/Deletion Polymorphisms
Polymorphism: A genetic variation that is observed at a frequency of >1% in a population
Why does drug response vary?Genetic variation
6
![Page 7: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/7.jpg)
SNPs are single base pair positions in genomic DNA at which different sequence alternatives (alleles) exist wherein the least frequent allele has an abundance of 1% or greater.
For example a SNP might change the DNA sequence
from AAGCTTAC
to ATGCTTAC
SNPs are the most commonly occurring genetic differences.
Single nucleotide polymorphism (SNP)
7
![Page 8: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/8.jpg)
SNPs are very common in the human population.
Between any two people, there is an average of one SNP every ~1250 bases.
Most of these have no phenotypic effect
− Venter et al. estimate that only <1% of all human SNPs impact protein function (lots of in “non-coding regions”)
Some are alleles of genes.
Single nucleotide polymorphism (SNP)
8
![Page 9: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/9.jpg)
Tandem repeats or variable number of tandem repeats (VNTR) are a very common class of polymorphism, consisting of variable length of sequence motifs that are repeated in tandem in a variable copy number.
Based on the size of the tandem repeat units:
− Venter et al. estimate that only <1% of all human SNPs impact protein function (lots of in “non-coding regions”)
Repeat unit: 1-6 (dinucleotide repeat: CACACACACACA)
− Minisatellites
Repeat unit: 14-100
Tandem repeat polymorphisms
9
![Page 10: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/10.jpg)
Insertion/Deletion (INDEL) polymorphisms are
quite common and widely distributed throughout
the human genome.
Insertion/deletion polymorphisms
10
![Page 11: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/11.jpg)
20-40% of patients benefit from an approved drug
70-80% of drug candidates fail in clinical trials
Many approved drugs removed from the market due to adverse drug effects
The use of DNA sequence information to measure and predict the reaction of individuals to drugs.
Personalized drugs
Faster clinical trials
Less drug side effects
Due to individual variation …
11
Pharmacogenetics
![Page 12: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/12.jpg)
“Study of inter-individual variation in DNA sequence related to drug absorption and disposition (Pharmacokinetics) and/or drug action (Pharmacodynamics) including polymorphic variation in genes that encode the functions of transporters, metabolizing enzymes, receptors and other proteins”
“The study of how people respond differently to medicines due to their genetic inheritance is called pharmacogenetics”
“Correlating heritable genetic variation to drug response”
An ultimate goal of pharmacogenetics is to understand how someone's genetic make-up determines, how well a medicine works in his or her body, as well as what side effects are likely to occur.
“Right medicine for the right patient”
Pharmacogenetics
12
![Page 13: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/13.jpg)
Pharmacogenetics: Study of variability in drug
response determined by single genes.
Pharmacogenomics: Study of variability in drug
response determined by multiple genes within
the genome.
Pharmacogenetics vs. pharmacogenomics
13
![Page 14: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/14.jpg)
Pharmacogenetics
The study of variations in genes that determine an individual’s response to drug therapy.
Common variation in DNA sequence (i.e. in >1% of population)
Genetic Polymorphism: SNPs; INDEL; VNTRs
Potential Target Genes are those that encode:Drug-metabolizing enzymesTransportersDrug targets
14
![Page 15: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/15.jpg)
Patient’s response to drug may depend on factors that can vary according to
the alleles that an individual carries, including:
Determinants of drug efficacy and toxicity
15
Pharmacologic effect
Clinical response
Toxicity Efficacy
DISTRIBUTION
ABSORPTION
ELIMINATION
Pharmacokinetics
Pharmacodynamics
dose administered
drug in tissuesof distribution
concentration insystemic circulation
concentration atsite of action
metabolism and/or excretion
Pharmacokinetic factors − Absorption
− Distribution
− Metabolism
− Elimination
Pharmacodynamic factors− Target proteins
− Downstream messengers
![Page 16: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/16.jpg)
EM phenotype: Extensive metabolizer; IM phenotype: intermediate metabolizer;
PM phenotype: poor metabolizer; UM phenotype: ultrarapid metabolizers
Examples
16
![Page 17: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/17.jpg)
Individual variations in drug response are frequently associated with three groups of protein:
ADME-associated proteins: proteins responsible for the absorption, distribution, metabolism and excretion (ADME) of drugs
Therapeutic targets: proteins that can be modified by an external stimulus (drug molecules).
ADR related proteins: drug adverse reaction related proteins
The factors in variations of drug responses:
Sequence polymorphism
Transcriptional processing of proteins: altered methylations of genes, differential splicing of mRNAS
Post-transcriptional processing of proteins: differences in protein folding, glycosylation, turnover and trafficking.
17
![Page 18: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/18.jpg)
Medicines are not safe or effective in all patients
18
![Page 19: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/19.jpg)
Medicines are not safe or effective in all patients
19
Drug Group Efficacy Incomplete/Absent
SSRI 10-25%
Beta blockers 15-25%
Statins 30-70%
Beta2 agonists 40-70%
…… ……
when considered in further detail, we can see that efficacy of some of our major drug classes vary from 10-70% incomplete efficacy.
![Page 20: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/20.jpg)
Pharmacogenetic prediction and mechanistic elucidation
of individual variations of drug responses is important
for facilitating the design of personalized drugs and
optimum dosages.
For most drugs, not all of the ADME-associated proteins
responsible for metabolism and disposition of
pharmaceutical agents are known.
The needs of prediction of pharmacogenetic response to drugs
20
![Page 21: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/21.jpg)
A number of studies have explored the possibility of using polymorphisms as indicators of specific drug responses.
Computational methods have been developed for analyzing complex genetic, expression and environmental data to analyze the association between drug response and the profiles of polymorphism, expression and environmental factors and to derive pharmacogenetic predictors of drug response
A number of Freely accessible internet resources
The feasibility of prediction of pharmacogenetic response to drugs
21
![Page 22: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/22.jpg)
Reported polymorphisms of ADME-associated proteins:By a comprehensive search of the abstracts of Medline database
The approach of prediction of pharmacogenetic response to drugs
22
![Page 23: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/23.jpg)
ADME-associated proteins linked to reported drug response variationsAlso by a comprehensive search of the abstracts of Medline database
The approach of prediction of pharmacogenetic response to drugs
23
![Page 24: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/24.jpg)
Rule-based prediction of drug responses from the polymorphisms of ADME-associated proteins
The approach of prediction of pharmacogenetic response to drugs
24
the analysis of clinical samples of the variation of drug responses
+the results of genetic analysis of the participating patients
Used as indicators for predicting individual variations of drug response
![Page 25: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/25.jpg)
Similar to the “Simple rules-based” method for using
HIV-1 genotype to predict antiretroviral drug
susceptibility (HIV drug resistant genotype
interpretation systems)*
* Comparative Evaluation of Three Computerized Algorithms for Prediction
of Antiretroviral Susceptibility from HIV Type 1 Genotype. J
Antimicrob Chemother 53, 356-360 (2004).
The approach of prediction of pharmacogenetic response to drugs
25
![Page 26: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/26.jpg)
26
Basic idea of using HIV-1 genotype to predict antiretroviral drug susceptibility
HIV-1 genotype 1
HIV-1 genotype 2
Phenotype resistant : drug 1, drug 2, drug 3…
Phenotype susceptible: drug a, drug b, drug c…
HIV-1 genotype 3
…
Phenotype resistant : drug 2, drug 3, drug a…
Phenotype susceptible: drug b, drug c…
Phenotype resistant : drug 1, drug 3…
Phenotype susceptible: drug 2, drug a…
Phenotype resistant : …
Phenotype susceptible:…
Drug 1: Genotype1: phenotype (penalty / score); Genotype2: phenotype (penalty / score); …Drug 2: Genotype1: phenotype (penalty / score); Genotype2: phenotype (penalty / score); …
![Page 27: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/27.jpg)
Examples of the ADME-associated proteins having a known pharmacogenetic polymorphism and a sufficiently accurate rule for predicting responses to a specific drug or drug group reported in the literature.
The approach of prediction of pharmacogenetic response to drugs
27
![Page 28: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/28.jpg)
Low predicting accuracies of simple rules based methods: 50%~100% (comparable to those of 81%~97% for predicting HIV drug resistance mutations from the HIV resistant genotype interpretation systems)
Variation of response to some drugs: associated with complex interaction of polymorphisms in multiple proteins
Simple rules:
Limited predicting capacity for prediction of drug responses
The basis for developing more sophisticated interpretation systems like those of the HIV resistant genotype interpretation system
Limitation of Simple rules based methods
28
![Page 29: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/29.jpg)
Computational methods for analysis and prediction of pharmacogenetics of drug responses from the polymorphisms of ADME-associated proteins
Examples recently explored for pharmacogenetic prediction of drug responses:
Discriminant analysis (DA) [Chiang et al., 2003]
Unconditional logistic regression [Yu et al., 2000]
Random regression model [Zanardi et al., 2001]
Logistic regression, 2004 [Zheng et al., 2004b]
Artificial neural networks (ANN) [Chiang et al., 2003; Serretti et al., 2004]
Maximum likelihood context model from haplotype structure provided by hapmap [Lin et al., 2005]
Other methods
29
![Page 30: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/30.jpg)
Statistical analysis and statistical learning methods used for pharmacogenetic prediction of drug responses
Examples
30
![Page 31: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/31.jpg)
Organisms are said to be drug-resistant when drugs meant to
neutralize them have reduced effect or even no effect.
Main cause of drug fail during the treatment of infectious disease ,
cancers (chemotherapy)
Main cause of the drug resistance:
Mutation in drug-interacting disease proteins (genetic resistance)
Development of alternative disease related pathway
What is the drug resistance?
31
![Page 32: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/32.jpg)
Example of drug resistance mutations
32
HIV-1
Protease mutations
(could be quickly
developed)
Integrase mutations
……Henderson L. and Arthur L. 2005. NIH AIDS Research and Reference Reagent Program
![Page 33: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/33.jpg)
The molecular analysis of drug resistance mechanisms
Design new agents to against resistant strains
Guide the clinical regimen to fight with disease
The needs for drug resistance mutations prediction
33
![Page 34: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/34.jpg)
Structure-based approaches molecular modeling approach evolutionary simulation model neural network model
Sequence-based approaches Statistical learning methods Neural networks (NN) (classification, association, regression) Support vector machines (SVM) )(classification, regression) Decision tree (DT) Simple rules (HIVdb, HIValg, ARS, and VGI etc)
Methods for mechanistic study and prediction of resistance mutations
34
![Page 35: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/35.jpg)
Methods for mechanistic study and prediction of resistance mutations
35
– Simple rules
Protein Mutations
Drugs
Genotypic
Phenotypic
PenaltyPenalty
PenaltyPenalty
PenaltyPenalty
PenaltyPenalty
PenaltyPenalty
Penalty
![Page 36: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/36.jpg)
Methods for mechanistic study and prediction of resistance mutations
36
– Simple rules
Penalty
Penalty
Penalty
PenaltyPenalty
PenaltyPenalty
Penalty
susceptiblepotential low-level resistancelow-level resistanceIntermediate resistancehigh-level resistance
![Page 37: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/37.jpg)
Methods for mechanistic study and prediction of resistance mutations
37
– Simple rules
![Page 38: Advanced Bioinformatics Lecture 9: Drug resistant & cancerous mutation](https://reader035.fdocument.pub/reader035/viewer/2022062807/568150af550346895dbecb80/html5/thumbnails/38.jpg)
Projects Q&A!
1. Biological pathway simulation
2. Computer-aided anti-cancer drug design
3. Disease-causing mutation on drug target
38
Any questions? Thank you!